New Horizons in the Development of Treatments for Substance Use Disorders
Abstract
Substance use disorders (SUDs) are a major public health problem in the United States and cause substantial morbidity and mortality. There are meaningful gaps in the available SUD treatment options, and the development of new therapies is urgently needed. While medications with U.S. Food and Drug Administration approval are available for alcohol, nicotine, and opioid use disorders, there are no approved pharmacotherapies for cannabis, cocaine, or methamphetamine use disorders. Behavioral treatments for SUDs have significant limitations in effectiveness and accessibility, and there is a need for the development of both new behavioral treatment options and new models of treatment delivery. The next generation of treatments for SUDs will likely come from a diverse set of interventions, including new drug classes, new technologies, and new methods of delivery.
Fields of Study & Subjects
Substance Abuse Treatment and Outcomes
Opioid Use Disorder Treatment
Forensic Toxicology and Drug Analysis
Publication details
- Journal / source
- American Journal of Psychiatry
- Publisher
- American Psychiatric Association Publishing
- Volume
- 183
- Issue
- 9
- Pages
- 615–623
- Publication date
- 1 September 2026
- Language
- EN